Isabell Kemker is a Lab Head in Peptide Chemistry at Bayer since January 2021, where responsibilities include identifying and optimizing peptides for various projects in cardiovascular and oncology research, leading an agile team, and collaborating with external partners. Previous experience includes a role as Scientist R&D at Roche, focused on the design and analysis of complex glycopeptides, and a PhD at Bielefeld University, where research concentrated on peptide synthesis and catalysis. Isabell also completed internships at Sandoz and the University of Wollongong, gaining valuable skills in industrial research and methodology development. Academic qualifications include a Dr. rer. nat. in Chemistry and Master's and Bachelor's degrees in Biochemistry, all from Bielefeld University.